-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
LivaNova PLC (NASDAQ:LIVN) Given Average Rating of "Buy" by Brokerages
LivaNova PLC (NASDAQ:LIVN) Given Average Rating of "Buy" by Brokerages
Shares of LivaNova PLC (NASDAQ:LIVN – Get Rating) have received a consensus recommendation of "Buy" from the six research firms that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $90.20.
Several analysts recently commented on the company. Needham & Company LLC decreased their price target on LivaNova from $106.00 to $88.00 and set a "buy" rating on the stock in a research note on Thursday, August 4th. StockNews.com raised LivaNova from a "hold" rating to a "buy" rating in a research note on Friday, September 9th. Finally, The Goldman Sachs Group decreased their price target on LivaNova from $85.00 to $73.00 and set a "buy" rating on the stock in a research note on Tuesday, August 16th.
Get LivaNova alerts:LivaNova Price Performance
Shares of NASDAQ:LIVN opened at $54.99 on Friday. LivaNova has a 1-year low of $53.28 and a 1-year high of $93.89. The firm has a market capitalization of $2.94 billion, a PE ratio of -98.20 and a beta of 0.91. The business's 50 day moving average is $60.85 and its 200-day moving average is $68.13. The company has a current ratio of 2.93, a quick ratio of 2.47 and a debt-to-equity ratio of 0.36.
LivaNova (NASDAQ:LIVN – Get Rating) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.53 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.02. The company had revenue of $254.20 million for the quarter, compared to analyst estimates of $249.55 million. LivaNova had a positive return on equity of 9.35% and a negative net margin of 2.74%. LivaNova's revenue for the quarter was down 3.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.52 EPS. Sell-side analysts predict that LivaNova will post 1.91 earnings per share for the current year.Institutional Investors Weigh In On LivaNova
A number of institutional investors and hedge funds have recently made changes to their positions in LIVN. Column Capital Advisors LLC raised its position in shares of LivaNova by 109.1% during the first quarter. Column Capital Advisors LLC now owns 345 shares of the company's stock worth $28,000 after acquiring an additional 180 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of LivaNova by 29.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 787 shares of the company's stock worth $49,000 after acquiring an additional 180 shares during the last quarter. Wolverine Asset Management LLC bought a new stake in LivaNova in the second quarter valued at about $67,000. Meeder Asset Management Inc. bought a new stake in LivaNova in the first quarter valued at about $155,000. Finally, Blair William & Co. IL bought a new stake in LivaNova in the fourth quarter valued at about $212,000. Institutional investors own 98.89% of the company's stock.
LivaNova Company Profile
(Get Rating)
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
Recommended Stories
- Get a free copy of the StockNews.com research report on LivaNova (LIVN)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
- Is There a Cure for What is Ailing Teladoc Stock?
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.
Shares of LivaNova PLC (NASDAQ:LIVN – Get Rating) have received a consensus recommendation of "Buy" from the six research firms that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $90.20.
據市場報道，Liva Nova PLC(納斯達克代碼：LIVN-GET Rating)的股票已收到目前追蹤該股票的六家研究公司一致給予的買入建議。五位分析師將該股的評級定為買入。在去年發佈該股報告的券商中，12個月目標價的平均水平為90.20美元。
Several analysts recently commented on the company. Needham & Company LLC decreased their price target on LivaNova from $106.00 to $88.00 and set a "buy" rating on the stock in a research note on Thursday, August 4th. StockNews.com raised LivaNova from a "hold" rating to a "buy" rating in a research note on Friday, September 9th. Finally, The Goldman Sachs Group decreased their price target on LivaNova from $85.00 to $73.00 and set a "buy" rating on the stock in a research note on Tuesday, August 16th.
幾位分析師最近對該公司發表了評論。8月4日，Needham&Company LLC將Liva Nova的目標價從106.00美元下調至88美元，並在一份研究報告中設定了該股的“買入”評級。在9月9日星期五的一份研究報告中，StockNews.com將LivaNova的評級從持有上調至買入。最後，高盛夫婦在8月16日星期二的一份研究報告中將Liva Nova的目標價從85.00美元下調至73.00美元，並對該股設定了買入評級。
LivaNova Price Performance
Liva Nova性價比
Shares of NASDAQ:LIVN opened at $54.99 on Friday. LivaNova has a 1-year low of $53.28 and a 1-year high of $93.89. The firm has a market capitalization of $2.94 billion, a PE ratio of -98.20 and a beta of 0.91. The business's 50 day moving average is $60.85 and its 200-day moving average is $68.13. The company has a current ratio of 2.93, a quick ratio of 2.47 and a debt-to-equity ratio of 0.36.
納斯達克：livn的股價上週五開盤報54.99美元。LivaNova的一年低點為53.28美元，一年高位為93.89美元。該公司的市值為29.4億美元，市盈率為-98.20，貝塔係數為0.91。該業務的50日移動均線切入位在60.85美元，200日移動均線切入位在68.13美元。該公司的流動比率為2.93，速動比率為2.47，債務權益比率為0.36。
Institutional Investors Weigh In On LivaNova
機構投資者對LivaNova的看法
A number of institutional investors and hedge funds have recently made changes to their positions in LIVN. Column Capital Advisors LLC raised its position in shares of LivaNova by 109.1% during the first quarter. Column Capital Advisors LLC now owns 345 shares of the company's stock worth $28,000 after acquiring an additional 180 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of LivaNova by 29.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 787 shares of the company's stock worth $49,000 after acquiring an additional 180 shares during the last quarter. Wolverine Asset Management LLC bought a new stake in LivaNova in the second quarter valued at about $67,000. Meeder Asset Management Inc. bought a new stake in LivaNova in the first quarter valued at about $155,000. Finally, Blair William & Co. IL bought a new stake in LivaNova in the fourth quarter valued at about $212,000. Institutional investors own 98.89% of the company's stock.
一些機構投資者和對衝基金最近改變了他們在livn的頭寸。Column Capital Advisors LLC在第一季度將其在Liva Nova股票的持倉提高了109.1%。Column Capital Advisors LLC在上個季度增持了180股後，現在擁有345股該公司股票，價值2.8萬美元。西北互惠財富管理公司在第二季度將其持有的Liva Nova股票的倉位提高了29.7%。西北互惠財富管理公司目前持有該公司787股股票，價值49,000美元，該公司在上個季度增持了180股股票。金剛狼資產管理有限責任公司在第二季度購買了LivaNova的新股份，價值約6.7萬美元。Meeder Asset Management Inc.在第一季度購買了LivaNova的新股份，價值約為155,000美元。最後，Blair William&Co.IL在第四季度購入了LivaNova的新股份，價值約為21.2萬美元。機構投資者持有該公司98.89%的股票。
LivaNova Company Profile
Liva Nova公司簡介
(Get Rating)
(獲取評級)
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
Liva Nova PLC是一家醫療設備公司，在全球設計、開發、製造和銷售治療解決方案。它通過三個部分運作：心肺、神經調節和高級循環支持。心肺部門開發、生產和銷售心肺產品，包括氧合器、心肺機、自體輸血系統、灌流管系統、套管、連接件和其他相關產品。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on LivaNova (LIVN)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
- Is There a Cure for What is Ailing Teladoc Stock?
- 免費獲取StockNews.com關於Liva Nova的研究報告(Livn)
- 第四季度值得考慮的3家銀行
- 股市：紅海中的三座強國
- MarketBeat：回顧一週9/12-9/16
- 沒有人告訴這三隻股票這是下跌的一週
- 有什麼辦法可以治癒Teladoc股票的問題嗎？
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.
接受Liva Nova Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊，接收Liva Nova和相關公司的最新新聞和分析師評級的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧